Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

A Systems Thinking Approach for Pharma

Posted on May 21st, 2020 by

Systems thinking asks scientists to look at the bigger picture and take a more holistic approach to their work. Systems thinkers consider how their field of study might relate to other disciplines, and how their research might inform or benefit from the broader knowledge stream. 

(more…)

Global networks form to take on the problem of drug-induced liver injury (DILI)

Posted on May 20th, 2020 by

Drug-induced liver injury (DILI), which is one of the top causes of liver failure in the United States [1], is an adverse reaction that can be caused by a significant number of medications. DILI can be fatal and is not only a major concern post-market, but also during drug development as it is the top safety-related reason for late-stage clinical trial failure.

(more…)

Partnering to identify repurposing candidates for chronic pancreatitis

Posted on May 12th, 2020 by

Take a look at this infographic demonstrating how leveraging Entellect and collaborating with three partners led to a datathon that delivered four potential repurposing candidates in just 60 days.

(more…)

Five drug development strategies to combat 2019 novel coronavirus

Posted on April 15th, 2020 by

This article was originally published on Feb 28, 2020, and has been updated on Apr 13, 2020.

Coronavirus disease 19 (COVID-19) has rapidly spread from its starting point in Wuhan, China. As of February 23, 2020, a total of 32 countries and territories have reported 78,811 cases (98% in China) and 2462 deaths [1]. The international scientific community is in a race against time. Researchers across the globe are collaborating to develop antivirals and vaccines to contain the spread of 2019 novel coronavirus (SARS-CoV-2).

(more…)

  1. 1
  2. 2
  3. 3
  4. 80